Aplagon Announces EUR 7 Million Financing to Advance its APAC Therapeutic for Thrombo-Inflammatory Diseases into Phase 2A Clinical Trials

Published on February 3, 2025

and LinkedIn . About Fåhraeus Startup and Growth Fåhraeus Startup & Growth (FSG) specializes in venture capital investments within the